A study of acquired and primary drug resistance in pulmonary tuberculosis has been made in the London Borough of Waltham Forest over the 15-year period 1953-68. Aetiology, clinical and bacteriological features, treatment, and prognosis are examined and contrasted for both groups of patients. The incidence of both types of resistance is compared with the national incidence and is considered in relation to Commonwealth immigration into the borough. Reasons are suggested for the decline of the acquired and the rise in the primary type of resistance. National surveys of drug-resistant tuberculosis have served a valuable purpose in focussing epidemiological attention on the many problems raised by this potentially dangerous form of the disease.
Although the prognosis of tuberculosis has improved remarkably in recent years, infection with drug-resistant organisms may frustrate the physician's intention to secure the best possible treatment for his patient. The necessity to initiate treatment weeks or months before the sensitivities of the bacillus can possibly be known involves the calculated risk that the drugs chosen may not be appropriate to the particular case. The use of a combination of drugs, which includes one or more to which the bacillus is resistant, may lead to the development of resistance to the companion drug, or drugs, a risk which is enhanced by any failure on the patient's part to adhere rigidly to the prescribed regimen. It is not an exaggeration to state that a patient's life may depend on the care with which chemotherapy is initially prescribed, and on the extent to which the physician can secure his active co-operation in a prolonged, irksome, and sometimes dangerous course of treatment.
Tuberculous patients may harbour resistant bacilli for two main reasons. When a newly diagnosed case is found to have resistant bacilli these are said to exhibit 'primary resistance,' which is presumed to be due to infection from a source case excreting resistant bacilli. 'Acquired resistance' occurs when a patient excreting initially sensitive strains of bacilli begins to excrete resistant bacilli as a result of inappropriate treatment. The amount of resistant disease in a community is thus a measure of the effectiveness with which antituberculosis chemotherapy has been deployed, and a high level of such resistance is evidence of bad treatment.
PRIMARY RESISTANCE
The Medical Research Council has estimated the prevalence of primary resistance to one or more of the three 'standard' drugs (streptomycin, paraaminosalycilic acid, and isoniazid) in the United Kingdom on two separate occasions. In 1955-6 the figure was 4 5% of newly diagnosed cases (Fox et al., 1957) and in 1963 it was 4-1 for the nation as a whole, but 21 % in London and south-east England (Miller et al., 1966 to have bacilli resistant to three drugs. As in the case of primary resistance, other evidence shows that the problem is much greater elsewhere. As far as the United Kingdom is concerned, the problem is probably a diminishing one. In Birmingham, Thomas (1963) demonstrated a falling incidence of acquired resistance following a peak in 1957, pointing out the considerable weighting of the drug-resistance register by patients notified in 1952-4, when the deployment of chemotherapy was comparatively unsophisticated. The mortality in these patients was high; up to half of those with multiple resistance were dead in five years. The scale of the problem was further reduced by successful treatment in most of the remainder, so that the public health danger diminished rather than increased, subsequent improvements in the standards of chemotherapy ensuring against its recurrence on a large scale. Experience in Wolverhampton (Aspin and Cross, 1962) confirmed the combined effect of mortality, further therapy, and normal healing in gradually eroding the problem of the resistant infector pool.
CLINICAL ASPECTS
The successful treatment of resistant tuberculosis calls for considerable experience and determination on the physician's part, since the affected patients are frequently unco-operative, truculent, unmotivated towards recovery, and unconvinced of the value of the treatment. Among the best reported results are those of Somner and Brace (1966) who, in a dedicated and tenacious enterprise, obtained sputum conversion in 22 out of 26 chronic cases by two years' continuous treatment using the reserve drugs, ethionamide, cycloserine, and pyrazinamide. Comparable results have also been reported by Zierski (1964) in Poland, Jan_i'k, Zelenka, Tousek, and Makova (1963) in Czechoslovakia, and Pines (1965) in this country; but the daunting nature of such undertakings was shown in a co-operative study by the British Tuberculosis Association (1963b) when, out of 117 patients, only 14 persisted with the prescribed year's course, nearly half having been withdrawn by their doctors because of toxic effects of the drugs used and over one-third having refused treatment or discharged themselves. The general results of treatment in this country are reflected in the report of the Chief Medical Officer of the Ministry of Health (1968 Of the 38 cases, 27 were men and 11 women. Table II shows that at the time when tuberculosis was originally diagnosed the men were considerably older than the women and that nine years elapsed on average between diagnosis and the positive identification of bacterial resistance. of the patients, and mostly on a domiciliary basis. In at least 9 of these 23 patients, chemotherapy had begun at the patient's home.
When the responsibility for the care of these patients passed to the newly formed Whipps Cross Hospital Chest Clinic, a serious attempt was made to establish their re-treatment on a rational basis. Many of them, however, proved refractory to the suggestion of a new approach, and several had difficult personalities engendered by years of ill health and the ineffectual treatment which must be regarded as the prime cause of the problem.
The case histories of this group showed that several patients had had genuine side effects which rendered treatment irksome; one had a severe isoniazid neuropathy and three probably suffered from mental changes due to isoniazid and cycloserine, but in no case could bacterial resistance be ascribed directly to side effects on the one hand or to hypersensitivity reactions on the other.
Among this group, many were finally persuaded to accept a new chemotherapy regimen, and in 9 out of 23 the disease was 'arrested' at the 1969 review. Eleven had died mostly due directly to active tuberculosis one had a positively discharging chest-wall sinus but healed pulmonary disease, and in two patients the disease was currently 'quiescent' under the influence of reserve chemotherapy. Further details are given in Table IV. Group 2 Unco-operative patient This group comprised 10 patients who appear to have been unco-operative from the start, this being the main cause of their drug-resistant infection. They were mainly recalcitrant people of the type known to every chest physician, disgruntled habitual defaulters or self-dischargers with defects of character amounting sometimes to frankly psychopathic states. Five discharged themselves against advice, three refused readmission, and three were admitted to mental hospitals, one having attempted suicide possibly due to isoniazid effects. One was mentally retarded and another was a likeable old miner with massive fibrosis and a casual attitude to his disease. In all of these patients, chemotherapy was first prescribed after 1952, and in most after 1956. All received initial treatment in hospital, correctly prescribed as triple (4 cases) or duple (6 cases) chemotherapy. Nevertheless, most (7) of this group failed to achieve negative sputum at first treatment, and it is likely that their failure to take drugs as prescribed dated from their first hospital admissions.
The mortality of this group was high, 7 out of Re-treatment and outcome In the 1950s the number and effectiveness of reserve drugs were very limited, so that several of the earlier patients in this series did not have reserve treatment of such a high standard as those who came later. Of the 19 patients who died, 15 had been prescribed regimens of reserve drugs but all failed to take them as prescribed. Several died at a time when the choice of reserve drugs was very limited.
Of the 19 patients who survived, 12 achieved arrest of disease by reserve drugs prescribed from 1960 onwards, usually in combinations of three or more, standard drugs also being used where sensitivities and expediency permitted. Ethionamide, cycloserine, and pyrazinamide were used in nearly all cases, and viomycin, tetracycline, thiacetazone, kanamycin, ethambutol, and capreomycin occasionally. In the successful cases, sputum conversion occurred mostly within a few months of starting re-treatment, which was usually continued for two years or more. Five further patients achieved negative bacteriology on reserve treatment but at the time of review cannot yet be considered to have arrested disease.
Only one patient continues to excrete resistant bacilli from a chest-wall sinus despite re-treatment. This is a case of empyema following an old thoracoplasty.
The status of all 38 patients in 1969 is given in Table IV , classified according to the aetiology of drug resistance. The best prognosis was in the group of patients in whom no obvious cause could be found, only one death occurring out of five patients. Next came the group whose initial treatment had been faulty, 11 dying out of 23. The unco-operative group fared worst, mainly because they would not accept re-treatment, and in this group 7 out of 10 died.
As might be expected from the data in Table II and the chronic nature of the disease, most of the deaths occurred between the ages of 50 and 70, the youngest being a Pakistani woman aged 25 with far advanced disease and multiple drug resistance acquired before entry to this country. Ten patients survived up to five years, and six up to 10 years after the diagnosis of drug resistance.
In this group of patients there was a tendency in individual cases for resistance to become multiple as time went on but occasionally the reverse happened. In two chronic isoniazid-resistant cases the bacilli became fully sensitive after an interval of two years or more during which none of the standard drugs had been prescribed. In Table V the number of standard drugs, for which resistance is quoted, is taken as the highest number recorded for each patient at any time. Several patients also had bacilli resistant to some of the reserve drugs. Single drug resistance was usually to isoniazid. When two drugs were involved, they were more often isoniazid and streptomycin in that order. Isoniazid was more often involved in drug resistance (34 cases) than streptomycin (28 cases) or para-aminosalicylic acid (25 cases). thus eight had one to two zones and four had three zones involved. All were co-operative and anxious to be cured except for one elderly Indian with kala-azar. In eight patients the bacilli were resistant to a single drug, in three they were resistant to two drugs, and only one patient showed triple resistance, details being shown in Table VI .
With the exception of the Indian with kala-azar (see later), all 12 patients were treated initially with standard triple chemotherapy, the intention being to continue daily streptomycin, PAS, and isoniazid for three months after which streptomycin would be discontinued and treatment completed with the other two drugs, for a total period of not less than 18 months. The receipt of sensitivity reports revealing resistance called for modifications of treatment. These are described according to the number of drugs involved, and the results are given.
Resistance to one drug (8 cases) A report of resistance to one drug was not specially disturbing, since reliance could be placed on the combined effectiveness to date of the remaining pair. Nevertheless, an alternative was usually prescribed in place of the ineffective drug, and this revised triple therapy was continued with a subsequently reduced weekly total of streptomycin, into the fifth or sixth month, when the streptomycin was finally discontinued. Progress at this stage was satisfactory in all eight patients and treatment was completed with two (occasionally three) oral preparations. More problems arose, in fact, out of hypersensitivity, toxic reaction, and intolerance to the drugs on the patients' part, than from drug resistance in the infecting bacilli; only three patients were free from such side effects, and many changes of treatment had to be made in the remainder. One only patient a Pakistani childhad a streptomycin-resistant infection, reported when she had already converted to negative sputum. In this case, duple therapy with PAS and isoniazid was continued as elective treatment. Satisfactory progress and follow-up were observed in all eight patients (2 to 7 years).
Resistance to tuwo drutgs (3 cases) Primary resistance to two drugs raised much more serious problems, and two of these three patients suffered a clinical relapse. The case histories are instructive and are briefly described:
(1) J. M., a white man aged 40, developed acute diEease in 1962 which regressed clinically and radiographically on initial triple therapy but his sputum remained positive and in the twelfth week of treatment the laboratory reported resistance to PAS and isoniazid (and also to cycloserine). Treatment The four cases of multiple drug resistance, however, proved a more taxing problem; relapse occurred in three of these, prior warning having been received in the form of the sensitivity reports in each.case. The warning was acted upon in two cases but, in spite of apparently correct treatment and good early progress, one had a late relapse. The warning was ignored in the third case; disastrous relapse followed, requiring surgical intervention to save life. Although the fourth case made an impressive early recovery from tuberculosis on 'correct' treatment, the follow-up period was cut short by early death from kala-azar.
Clearly, single-drug resistance is noteworthy, and calls for modifications in treatment but has a favourable prognosis if triple therapy is prescribed initially. In contrast, resistance to two or more drugs requires urgent and radical reconsideration of treatment, and relapse is likely.
DISCUSSION
The number of resistant cases recorded prior to 1960 almost certainly represents an underestimate, since epidemiological interest in the problem was not specially aroused at that time. By 1960, however, the problem had claimed attention, and at the time of the British Tuberculosis Association's national survey of acquired resistance of 1960-1 there were 19 such patients living in Waltham Forest, an incidence of about 8 per 100,000, which compares with the survey's current estimate of 6-2 per 100,000 for the country as a whole.
In the years following 1960, special attention was paid to the problem and the number of patients developing acquired resistance became progressively fewer, so that in the five-year period, 1964-8 inclusive, only eight further cases of acquired resistance came to light, five of which had been notified as tuberculous at least two years previously.
Turning to primary resistance, there is again a rough correlation between the figure presented here for Waltham Forest and that established for London and south-east England in the Medical Research Council's survey of 1963. In Waltham Forest only 12 cases were recorded between 1960 and 1968 inclusive out of 760 new cases of the disease, an incidence of 1-6% as against a regional figure of 2-1 % in the M.R.C. survey. Only for the years 1964-8 inclusive do the local figures approximate to the national, when 10 primarily resistant cases were recorded out of a total of 379 new cases, an incidence of 3 8 % as against 4-1 % recorded nationally by the M.R.C. for 1963. The explanation for the rising incidence from 1964 onwards is found in the big increase in notifications of Commonwealth immigrants which occurred at that time (Table VII) .
In fact the bulk of primarily resistant cases was derived from Commonwealth immigrants who were estimated by 1968 to constitute 8 5% of the borough's population (Wright, 1969) . Table VIII shows the big difference between the incidence of such cases in immigrants (9 0) and patients originating in Britain (07%). WALIHAM FOREST 1961 -8 1961 1962 1963 1964 1967 1968 British (Marks, 1965) , work which has since come to be concentrated in specialized laboratories.
CONCLUSIONS
A survey of drug-resistant pulmonary tuberculosis in Waltham Forest shows that acquired drug resistance is found in older patients with chronic disease. When this is due to an unco-operative patient the prognosis is bad; when due to previous faulty treatment it is better; and when no cause can be ascribed it is good. The local incidence of this type of case has been average for the nation and is now falling. The incidence of primary drug resistance in Waltham Forest has been lower than the national average; it has risen due to the influx of Commonwealth immigrants since 1964, and can be expected to continue to rise. Such patients are younger and are anxious to be cured; they present few major problems in treatment, provided resistance is to one drug only. Those 
